ResearchMoz

Sitagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Publisher Name » GenericsWeb
Published Date » 2011-12-01
No. Of Pages » N/A

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.

This Pipeline Selector report covers Sitagliptin

  • Sitagliptin indications: Improvement of glycemic control in patients with type 2 diabetes mellitus; used alone or in combination with Metformin or a PPARy agonist.
  • Sitagliptin innovator: Merck (Januvia, Janumet)
Examples of information found in this online report include:

  • Includes key patent publications for 44 countries (see list below)
  • Contains SPC protection for every EU state plus patent term extensions in other countries
  • Data exclusivity calculated on a country by country basis
  • Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
  • DMF & Paragraph IV filings
  • Litigation alerts
  • Marketing authorisation holders in selected territories
  • Patent risk analysis via graphical display of data from patent filings
  • Hyper-linking to crucial patent documents and national registries enabling data verification
The 'Key Patent Indicator' enables easy identification of key patent, SPC and data protection expiry information covering 44 countries, including extension details (SPC and national law) for 30 European countries, Australia, Israel, Japan and the USA. (also available with 44 country coverage):

Pipeline Selector 44 Country Coverage:

  • Country Region Extensions
  • Australia Asia-Pacific S70
  • Canada Americas N/A
  • USA Americas S156
  • Germany Western Europe SPC
  • Great Britain Western Europe SPCS
  • France Western Europe NAT/SPC
  • Spain Western Europe SPC
  • South Africa Africa N/A
  • China Asia-Pacific N/A
  • Japan Asia-Pacific S67
  • New Zealand Asia-Pacific N/A
  • Bosnia & Herzegovina Balkan N/A
  • Bulgaria Balkan SPC
  • Croatia Balkan N/A
  • Romania Balkan SPC
  • Slovenia Balkan NAT/SPC
  • Estonia Baltic NAT/SPC
  • Lithuania Baltic NAT/SPC
  • Latvia Baltic NAT/SPC
  • Czech Republic Central Europe NAT/SPC
  • Hungary Central Europe SPC
  • Poland Central Europe SPC
  • Slovakia Central Europe NAT/SPC
  • Serbia & Montenegro Central Europe N/A
  • Cyprus Mediterranean NAT/SPC
  • Greece Mediterranean SPC
  • Israel Mediterranean NAT
  • Malta Mediterranean SPC
  • Turkey Mediterranean N/A
  • Denmark Scandinavia SPC
  • Finland Scandinavia SPC
  • Iceland Scandinavia SPC
  • Norway Scandinavia SPC
  • Sweden Scandinavia SPC
  • Brazil South America N/A
  • Mexico South America N/A
  • Austria Western Europe SPC
  • Belgium Western Europe SPC
  • Switzerland Western Europe NAT/SPC
  • Ireland Western Europe SPC
  • Italy Western Europe NAT/SPC
  • Luxembourg Western Europe SPC
  • The Netherlands Western Europe SPC
  • Portugal Western Europe SPC
Other key information contained in the report:

  • Summary of dosage forms, strengths, indications and active ingredient forms of the brand product in major countries**. 
  • News articles
  • Litigation alerts
  • Marketing authorisation holders for Great Britain, the United States, Canada and Australia enable you to see who is active in the market.
  • US Drug Master Files, providing valuable information to help source active ingredients and keep an eye on competitors.
  • Paragraph IV filing; details of US ANDAs filed with a Paragraph IV certification allow easy determination of who the first movers are for a particular generic product in the US.
  • 'Patent Risk Analysis' section containing three graphical displays of data drawn from known patent filings to provide valuable competitor insight and development information***.
Key Patent Indicator

The 'Key Patent Indicator' section is intended only to provide an indication of the Key Patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding Pipeline Selector report). 

General Drug Information

Information contained in 'General Indications' and 'Brand Product Attributes' is based on products containing the active pharmaceutical ingredient, which are currently registered in Australia, UK and the USA. Indications are summarised where appropriate and may vary between individual countries.

Patent Risk Analysis

The three graphical analyses are based on data contained in our Pipeline Selector comprehensive patent search, and thus are subject to its scope and limitations. These graphics are intended to provide only a summary of the patent filings; specific details of the filings should be investigated through the use of the Pipeline Selector reports.

Pipeline Selector is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite.
NA

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Oral Hygiene Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
An increase in ageing population and rising demand for oral care are offering enormous opportunities for product innovations and developments to oral care providers. Rising awareness of oral care and the quality of services provided by dental care providers are some important factors driving the oral hygiene market. In addition to this, innovative products development and rising demand for aesthetic dentistry in developing nations is expected to drive the growth of the oral hygiene industry.  Emerging technologies will have a great impact on the overall growth of this...
Animal Food Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
Increasing concerns of pet owners about their pets' health, healthy pet food, and improved care are some of the major factors responsible for the growth of animal food market. Animal food market has developed rapidly in the past few years thus resulting in the introduction of a number of animal food manufacturing companies in this market. Changing demographics, new trends, and the increasing concerns about animals have led to the development of this market and rise in consumer expenditure on pets. The animal food market is changing dynamically and becoming vastly competitive...
Mobile Entertainment Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The continuous adoption of smart phones and the corresponding rise in application downloads are some of the major factors driving the mobile entertainment market. Mobile gambling and social media are the fastest growing segments of the mobile entertainment industry. The mobile entertainment industry is expected to witness a considerable growth rate of about USD 54 billion over the year 2015 due to an increasing usage of mobile apps and developments in different segments like mobile TV, mobile music, and many more. Services like social media, video, games, and streamed music are...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...